Adverse Effects of α1-Adrenergic Blocking Drugs

Drug Safety

Volumn 11, Issue 1, 1994, Pages 12-20

  Carruthers, S George ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FINASTERIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; NITRATE; PHENOXYBENZAMINE; PHENTOLAMINE; POSTSYNAPTIC RECEPTOR; PRAZOSIN; TERAZOSIN;

ASTHENIA; BLOOD TOXICITY; BODY POSTURE; CARDIOTOXICITY; CATALEPSY; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; FAINTNESS; HEADACHE; HEART PALPITATION; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; META ANALYSIS; NARCOLEPSY; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; PHEOCHROMOCYTOMA; PRIAPISM; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; RISK MANAGEMENT; SYMPATHETIC TONE; SYNCOPE; URINE FLOW RATE; URINE INCONTINENCE; VERTIGO; WEIGHT GAIN;

ADRENERGIC ALPHA-ANTAGONISTS; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGE; PRAZOSIN;

EID: 0028173804     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-199411010-00003     Document Type: Review

References (41)

1. Prazosin: severe side effects are dose-dependent
2. Role of selective alpha-1 blockers in the therapy of hypertension
3. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension
4. Prazosin
5. Alpha-adrenergic receptor blockade with prazosin: consideration of hypertension, heart failure and potential new applications
6. Orthostatic hypotension after the first administration of prazosin in hypertensive patients: role of the plasma volume
7. Treatment of hypertension with prazosin. An open study in general practice
8. for The Alpha Beta Canada (ABC) Trial Group. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension
9. Coronary risk prediction in adults (the Framingham Heart Study)
10. Therapeutic application of prazosin in chronic refractory congestive heart failure
11. for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
12. for The Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results
13. Treatment of mild hypertension. The more things change… [editorial]
14. Hypersensitivity to prazosin
15. Positive antinuclear factor tests with prazosin [letter]
16. Prazosin
17. Prazosin treatment complicated by acute febrile polyarthritis [letter]
18. Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin
19. Hypothermia: a possible side effect of prazosin
20. Decreased rectal body temperature induced by different vasodilatory drugs
21. Severe hypotension during epidural anesthesia in a prazosin-treated patient
22. Alpha-adrenergic hyper-responsiveness in asthma
23. Alpha-adrenergic antagonists in asthmatic patients: a note of caution [letter]
24. Prazosin in hypertensive patients with chronic bronchitis and asthma: a brief report
25. Faecal incontinence resulting from alpha 1-adrenoceptor blockade [letter]
26. Urinary incontinence secondary to prazosin
27. Prazosin-induced stress incontinence
28. Prazosin-induced priapism [letter]
29. Prazosin induced priapism in a patient on continuous ambulatory peritoneal dialysis (CAPD)
30. Priapism in haemodialysis patient due to prazosin? [letter]
31. Prazosin-induced priapism. Pathogenic and therapeutic implications [letter]
32. Initial experience with prazosin in New Zealand: a multi-center report
33. Prazosin-induced first-dose phenomenon possible associated with hemorrhagic stroke: a report of three cases
34. Comment: prazosin associated with stroke [letter]
35. Exacerbations of human cataplexy by prazosin
36. Leukocyte and bone marrow effects of a thiomorpholine quinazosin antihypertensive agent
37. Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics
38. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension
39. When is loss of responsiveness to a vasodilator agent in the patient with congestive heart failure due to tachyphylaxis? [editorial]